AdAlta (ASX:1AD) is the pioneer of a novel technology platform that mimics the shape and engineers key stability features of the antigen binding domain of shark antibodies into human proteins to create unique compounds, known as i-bodies, for therapeutic intervention in disease.

AdAlta is utilising the power of its i-body technology platform to develop a pipeline of i-bodies (drugs), with an initial focus on treating fibrotic diseases.

Biotechnology

Health Care

Therapeutics

AdAlta Ltd

AdAlta Ltd's headquarters in Melbourne, Australia

Description

People (3)

Tim Oldham

Angus Tester

Cameron Jones

Jobs